Nektar Therapeutics
NKTR
NKTR
154 hedge funds and large institutions have $84.2M invested in Nektar Therapeutics in 2025 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 42 increasing their positions, 47 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
11% less repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 47
32% less capital invested
Capital invested by funds: $124M → $84.2M (-$39.4M)
Holders
154
Holding in Top 10
–
Calls
$885K
Puts
$123K
Top Buyers
| 1 | +$2.51M | |
| 2 | +$1.9M | |
| 3 | +$1.1M | |
| 4 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
+$809K |
| 5 |
USPCM
Union Square Park Capital Management
New York
|
+$748K |
Top Sellers
| 1 | -$8.99M | |
| 2 | -$1.84M | |
| 3 | -$1.52M | |
| 4 |
ACM
Altium Capital Management
New York
|
-$1.33M |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$1.06M |
